Jingmin Jin

Title: Innovations by Jingmin Jin in RNA Detection

Introduction

Jingmin Jin is an accomplished inventor based in Middleton, MA (US). He has made significant contributions to the field of molecular biology, particularly in the detection of small RNAs. His innovative approaches have the potential to enhance diagnostic methods for various pathological conditions.

Latest Patents

Jingmin Jin holds a patent titled "Methods and compositions for detection and enrichment of target small RNAs." This patent describes methods and compositions for detecting small target RNAs, which may be either single-stranded or double-stranded. The techniques utilize a p19 fusion protein that binds to double-stranded RNA in a size-specific but sequence-independent manner. This protein can also attach to matrices such as beads or plastic microwell plates. By labeling the p19 fusion protein or the target RNA in a polynucleotide duplex, low levels of target RNA, including microRNAs, can be detected from cells. This innovation has significant implications for diagnosing various pathological conditions.

Career Highlights

Jingmin Jin is currently associated with New England Biolabs, Inc., where he continues to advance research in molecular biology. His work has been instrumental in developing methods that improve the detection of small RNAs, which are crucial for understanding various biological processes and diseases.

Collaborations

Jingmin Jin has collaborated with notable colleagues, including Larry A McReynolds and Lawrence Mcreynolds. These collaborations have fostered a productive research environment, leading to advancements in RNA detection technologies.

Conclusion

Jingmin Jin's innovative work in RNA detection exemplifies the impact of scientific research on medical diagnostics. His contributions are paving the way for improved methods in the detection of small RNAs, which can significantly enhance our understanding of various diseases.